• Diane Keaton, Oscar-winning actor who rose to fame…
  • AI data centers boom out West
  • Savewith a NBCUniversal ProfileCreate your free profile or…
  • Oct. 11, 2025, 8:00 AM EDTBy Alicia Victoria…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Chicago students met with Pope Leo after mock conclave

admin - Latest News - October 10, 2025
admin
8 views 6 secs 0 Comments



Chicago students met with Pope Leo after mock conclave



Source link

TAGS:
PREVIOUS
Sept. 29, 2025, 5:02 PM EDTBy Rebecca ShabadWASHINGTON — President Donald Trump on Monday unveiled a comprehensive peace proposal to end the war in Gaza, nearly two years after Hamas’ Oct. 7, 2023, attack on Israel.During his visit with Trump at the White House, Israeli Prime Minister Benjamin Netanyahu publicly backed the 20-point plan, but Trump acknowledged that Hamas had not agreed to it.The key components of the proposal include the release of all living and dead hostages in Gaza, a requirement for Hamas to lay down its arms, a withdrawal of Israeli troops from the territory, the delivery of humanitarian aid and the installation of a civilian governing authority for Palestinians.Trump said that if Hamas rejects the deal, he would back Netanyahu in dismantling and destroying Hamas.Here is the full text of the plan:Gaza will be a deradicalized terror-free zone that does not pose a threat to its neighbors.Gaza will be redeveloped for the benefit of the people of Gaza, who have suffered more than enough.If both sides agree to this proposal, the war will immediately end. Israeli forces will withdraw to the agreed upon line to prepare for a hostage release. During this time, all military operations, including aerial and artillery bombardment, will be suspended, and battle lines will remain frozen until conditions are met for the complete staged withdrawal.Within 72 hours of Israel publicly accepting this agreement, all hostages, alive and deceased, will be returned.Once all hostages are released, Israel will release 250 life sentence prisoners plus 1700 Gazans who were detained after October 7th 2023, including all women and children detained in that context. For every Israeli hostage whose remains are released, Israel will release the remains of 15 deceased Gazans.Once all hostages are returned, Hamas members who commit to peaceful co-existence and to decommission their weapons will be given amnesty. Members of Hamas who wish to leave Gaza will be provided safe passage to receiving countries.Upon acceptance of this agreement, full aid will be immediately sent into the Gaza Strip. At a minimum, aid quantities will be consistent with what was included in the January 19, 2025, agreement regarding humanitarian aid, including rehabilitation of infrastructure (water, electricity, sewage), rehabilitation of hospitals and bakeries, and entry of necessary equipment to remove rubble and open roads. Entry of distribution and aid in the Gaza Strip will proceed without interference from the two parties through the United Nations and its agencies, and the Red Crescent, in addition to other international institutions not associated in any manner with either party. Opening the Rafah crossing in both directions will be subject to the same mechanism implemented under the January 19, 2025 agreement.Gaza will be governed under the temporary transitional governance of a technocratic, apolitical Palestinian committee, responsible for delivering the day-to-day running of public services and municipalities for the people in Gaza. This committee will be made up of qualified Palestinians and international experts, with oversight and supervision by a new international transitional body, the “Board of Peace,” which will be headed and chaired by President Donald J. Trump, with other members and heads of State to be announced, including Former Prime Minister Tony Blair. This body will set the framework and handle the funding for the redevelopment of Gaza until such time as the Palestinian Authority has completed its reform program, as outlined in various proposals, including President Trump’s peace plan in 2020 and the Saudi-French proposal, and can securely and effectively take back control of Gaza. This body will call on best international standards to create modern and efficient governance that serves the people of Gaza and is conducive to attracting investment.A Trump economic development plan to rebuild and energize Gaza will be created by convening a panel of experts who have helped birth some of the thriving modern miracle cities in the Middle East. Many thoughtful investment proposals and exciting development ideas have been crafted by well-meaning international groups, and will be considered to synthesize the security and governance frameworks to attract and facilitate these investments that will create jobs, opportunity, and hope for future Gaza.A special economic zone will be established with preferred tariff and access rates to be negotiated with participating countries.No one will be forced to leave Gaza, and those who wish to leave will be free to do so and free to return. We will encourage people to stay and offer them the opportunity to build a better Gaza.Hamas and other factions agree to not have any role in the governance of Gaza, directly, indirectly, or in any form. All military, terror, and offensive infrastructure, including tunnels and weapon production facilities, will be destroyed and not rebuilt. There will be a process of demilitarization of Gaza under the supervision of independent monitors, which will include placing weapons permanently beyond use through an agreed process of decommissioning, and supported by an internationally funded buy back and reintegration program all verified by the independent monitors. New Gaza will be fully committed to building a prosperous economy and to peaceful coexistence with their neighbors.A guarantee will be provided by regional partners to ensure that Hamas, and the factions, comply with their obligations and that New Gaza poses no threat to its neighbors or its people.The United States will work with Arab and international partners to develop a temporary International Stabilization Force (ISF) to immediately deploy in Gaza. The ISF will train and provide support to vetted Palestinian police forces in Gaza, and will consult with Jordan and Egypt who have extensive experience in this field. This force will be the long-term internal security solution. The ISF will work with Israel and Egypt to help secure border areas, along with newly trained Palestinian police forces. It is critical to prevent munitions from entering Gaza and to facilitate the rapid and secure flow of goods to rebuild and revitalize Gaza. A deconfliction mechanism will be agreed upon by the parties.Israel will not occupy or annex Gaza. As the ISF establishes control and stability, the Israel Defense Forces (IDF) will withdraw based on standards, milestones, and timeframes linked to demilitarization that will be agreed upon between the IDF, ISF, the guarantors, and the Unites States, with the objective of a secure Gaza that no longer poses a threat to Israel, Egypt, or its citizens. Practically, the IDF will progressively hand over the Gaza territory it occupies to the ISF according to an agreement they will make with the transitional authority until they are withdrawn completely from Gaza, save for a security perimeter presence that will remain until Gaza is properly secure from any resurgent terror threat.In the event Hamas delays or rejects this proposal, the above, including the scaled-up aid operation, will proceed in the terror-free areas handed over from the IDF to the ISF.An interfaith dialogue process will be established based on the values of tolerance and peaceful co-existence to try and change mindsets and narratives of Palestinians and Israelis by emphasizing the benefits that can be derived from peace.While Gaza re-development advances and when the PA reform program is faithfully carried out, the conditions may finally be in place for a credible pathway to Palestinian self-determination and statehood, which we recognize as the aspiration of the Palestinian people.The United States will establish a dialogue between Israel and the Palestinians to agree on a political horizon for peaceful and prosperous co-existence.Rebecca ShabadRebecca Shabad is a politics reporter for NBC News based in Washington.
NEXT
Wisconsin shooting victim gets celebratory release
Related Post
September 29, 2025
White House Threatens Layoffs If Government Shuts Down
October 1, 2025
White House withdraws E.J. Antoni's nomination to run the Bureau of Labor Statistics
September 22, 2025
By Berkeley Lovelace Jr., Aria Bendix and Erika EdwardsPresident Donald Trump said Monday the Food and Drug Administration approved a chemotherapy drug called leucovorin as a treatment to alleviate symptoms of autism, despite little evidence that the medication works.Trump also said the administration is issuing a warning to doctors not to recommend acetaminophen — the active ingredient in Tylenol and other widely used medications — for pregnant women, claiming it may be linked to autism in children. Trump had been teasing the announcement for days, as Health Secretary Robert F. Kennedy Jr. and other health officials have pledged to determine the cause of the developmental disorder by September.The administration had planned to release its long-awaited report on causes of autism around Sept. 29 or Sept. 30, a person familiar with the matter told NBC News. But Trump pre-empted the rollout over the weekend, and details soon appeared in The Washington Post.“We understood a lot more than a lot of people who studied it,” Trump said from the White House, referring to autism. He spoke alongside Kennedy, Food and Drug Administration Commissioner Marty Makary, National Institutes of Health Director Jay Bhattacharya and Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services. ”Taking Tylenol is not good,” Trump said. “I’ll say it. It’s not good.”Leucovorin is a drug approved by the FDA to counteract the side effects of certain chemotherapy drugs and sometimes used off-label to treat vitamin B9 deficiency. Leucovorin is a form of folinic acid, a B vitamin. It has shown promise in clinical trials with helping some children with autism improve their speech. But the Autism Science Foundation, which funds evidence-based autism research, does not recommend it as a treatment yet and says more studies are needed.Trump said the FDA updated the drug’s label Monday for the treatment of autism symptoms. Oz said Medicaid — in partnership with states — will cover it with a prescription.“We believe insurance companies will rapidly follow our lead,” he said.Kennedy also said the FDA will issue a letter advising health care providers that the over-the-counter medication should be used during pregnancy only in cases of high fever, when the fever itself may pose a health risk to the fetus. The FDA’s notice, sometimes called a “Dear Doctor” letter, is meant to alert physicians and other prescribers about urgent or clinically significant safety issues it has identified with a drug. Kennedy also said the FDA will begin the process to initiate a safety label change for the drug.Bhattacharya said at Monday’s briefing that the NIH will dedicate $50 million to 13 research projects focused on identifying root causes and treatments for autism, an effort known as the “autism data science initiative.” The research will focus on environmental and medical factors, nutrition, events during pregnancy, biology and genetics, he said.“Given this wide range of symptoms across the spectrum, it seems certain that there will be a wide range of biological contributors to explaining the cause,” he said.Researchers who’ve spent decades researching potential causes of autism say the administration hasn’t uncovered any new evidence — and the existing data still doesn’t support its claims.“This is not new,” Dr. Allison Bryant, a high-risk obstetrician at Massachusetts General Hospital in Boston, said in an earlier interview. “It has bubbled up every now and again with studies that show maybe some kind of association but not clearly showing any cause and effect.”Experts say autism spectrum disorder, which is characterized by challenges with social and speech skills and by repetitive behaviors, most likely stems from multiple factors rather than a single cause. It affects 1 in 31 children in the United States, according to the Centers for Disease Control and Prevention.The bulk of scientific research hasn’t identified a link between acetaminophen and autism.“The science hasn’t changed regardless of what comes out from the report,” said Brian K. Lee, a professor of epidemiology at Drexel University in Philadelphia, referring to the Trump administration’s finding. “I’m not sure what the administration is doing, but it looks like they’re just going back and reviewing the evidence and they’re coming to a different conclusion than many scientists would.”Acetaminophen was introduced in the United States in the 1950s as a prescription alternative to aspirin. By the 1970s, it had been made available over the counter and became one of the most commonly used pain and fever medications in the country. The American College of Obstetricians and Gynecologists and other major medical groups say acetaminophen is one of the only safe pain relievers for women during pregnancy, and studies have shown no clear evidence that use during pregnancy leads to developmental issues in kids. The drug is also found in name brands like Theraflu and Excedrin.Forty percent to 65% of women use acetaminophen at some point during pregnancy, according to a 2014 study published in the American Family Physician.Earlier Monday, White House press secretary Karoline Leavitt touted a “major announcement” from Trump, telling reporters at a briefing to go into the autism announcement with “some critical thinking skills and with some open ears.”“They are paying attention to studies, and the gold standard of science and research, that many in this city for far too long have turned a blind eye to,” she said.Trump administration officials are citing previous research, including a literature review Mount Sinai and Harvard researchers published last month in the journal BMC Environmental Health. The review concluded there was most likely an association between autism and acetaminophen exposure during pregnancy. Outside autism researchers, however, said that the review wasn’t rigorously conducted and that it cherry-picked studies that supported its conclusion. The review’s senior author, Andrea Baccarelli, served in 2023 as a paid expert in a class action lawsuit against acetaminophen manufacturers, in which he testified that there was a link between the medication and autism. A judge ultimately excluded his testimony for being scientifically unsound and last year dismissed the case, which is being appealed.Baccarelli said in a statement that he and his colleagues conducted a rigorous review and that the association with neurodevelopmental disorders was strongest when acetaminophen was taken for four weeks or longer. He said he discussed his findings with Kennedy and Bhattacharya in recent weeks.“Further research is needed to confirm the association and determine causality, but based on existing evidence, I believe that caution about acetaminophen use during pregnancy — especially heavy or prolonged use — is warranted,” Baccarelli said.However, other autism researchers have pointed to a large study last year published in the Journal of the American Medical Association, which found no link between acetaminophen use in pregnancy and autism, ADHD or intellectual disability. The study, from Lee and his colleagues in Sweden, analyzed data from more than 2.4 million children. When the researchers looked solely at children with autism, there was a small increased risk possibly associated with acetaminophen. But when the researchers compared siblings within the same families — one exposed during pregnancy, the other not — the link disappeared. The comparison allowed them to control for variables that past studies couldn’t. Siblings share a large part of their genetic background and often have similar environmental exposures in utero and at home.“The biggest elephant in the room here is genetics,” Lee said. “We know that autism, ADHD and other neurodevelopmental disorders are highly heritable.”In an emailed statement, a spokesperson for Kenvue, the maker of Tylenol, said the drug is the safest pain reliever option for pregnant women.“Without it, women face dangerous choices: suffer through conditions like fever that are potentially harmful to both mom and baby or use riskier alternatives,” the spokesperson said. “We believe independent, sound science clearly shows that taking acetaminophen does not cause autism.”Bryant, of Massachusetts General Hospital, said, “The best science that we have available would still suggest that acetaminophen is a safe pain reliever and fever reducer in pregnancy.”Berkeley Lovelace Jr.Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.Aria BendixAria Bendix is the breaking health reporter for NBC News Digital.Erika EdwardsErika Edwards is a health and medical news writer and reporter for NBC News and “TODAY.”
October 2, 2025
Water cannon intercepts boat in Gaza aid flotilla
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved